Antimicrobial Activities of Garenoxacin (BMS 284756) against Asia-Pacific Region Clinical Isolates from the SENTRY Program, 1999 to 2001

Between 1999 and 2001, 16,731 isolates from the Asia-Pacific Region were tested in the SENTRY Program for susceptibility to six fluoroquinolones including garenoxacin. Garenoxacin was four- to eightfold less active against Enterobacteriaceae than ciprofloxacin, although both drugs inhibited similar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Christiansen, K. J., Bell, J. M., Turnidge, J. D., Jones, R. N.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2004
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC415570/
https://ncbi.nlm.nih.gov/pubmed/15155198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.6.2049-2055.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars